Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs

[FDA]

This guidance provides recommendations for the design and conduct of studies to evaluate the in 17 vivo skin irritation and sensitization (I/S) potential of a proposed transdermal or topical delivery 18 system (collectively referred to as TDS2).


Baca selengkapnya di : http://www.fda.gov...